Patent Assignment
Reel/Frame 056065/0763
Merger
Recorded: 2021-04-28
Pages: 9
Assignor
TOLERO PHARMACEUTICALS, INC.
Executed: 2020-07-01
Assignee
BOSTON BIOMEDICAL, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application:
17/090,857 →
Publication:
US 2021/0238183
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 28, 2021
From: XU, YONG; BRENNING, BEJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 056077/0341 →
Change of Name
Apr 28, 2021
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 056077/0354 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →